179 related articles for article (PubMed ID: 17620349)
1. Intranasal immunization with Gal-inhibitable lectin plus an adjuvant of CpG oligodeoxynucleotides protects against Entamoeba histolytica challenge.
Ivory CP; Chadee K
Infect Immun; 2007 Oct; 75(10):4917-22. PubMed ID: 17620349
[TBL] [Abstract][Full Text] [Related]
2. CpG-oligodeoxynucleotide is a potent adjuvant with an Entamoeba histolytica Gal-inhibitable lectin vaccine against amoebic liver abscess in gerbils.
Ivory CP; Keller K; Chadee K
Infect Immun; 2006 Jan; 74(1):528-36. PubMed ID: 16369009
[TBL] [Abstract][Full Text] [Related]
3. Adherence-inhibitory intestinal immunoglobulin a antibody response in baboons elicited by use of a synthetic intranasal lectin-based amebiasis subunit vaccine.
Abd Alla MD; White GL; Rogers TB; Cary ME; Carey DW; Ravdin JI
Infect Immun; 2007 Aug; 75(8):3812-22. PubMed ID: 17526742
[TBL] [Abstract][Full Text] [Related]
4. Prevention of intestinal amebiasis by vaccination with the Entamoeba histolytica Gal/GalNac lectin.
Houpt E; Barroso L; Lockhart L; Wright R; Cramer C; Lyerly D; Petri WA
Vaccine; 2004 Jan; 22(5-6):611-7. PubMed ID: 14741152
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the C-Terminal Fragment of Entamoeba histolytica Gal/GalNAc Lectin Intermediate Subunit as a Vaccine Candidate against Amebic Liver Abscess.
Min X; Feng M; Guan Y; Man S; Fu Y; Cheng X; Tachibana H
PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004419. PubMed ID: 26824828
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of a Gal-lectin subunit vaccine against experimental Entamoeba histolytica infection and colitis in baboons (Papio sp.).
Abd Alla MD; Wolf R; White GL; Kosanke SD; Cary D; Verweij JJ; Zhang MJ; Ravdin JI
Vaccine; 2012 Apr; 30(20):3068-75. PubMed ID: 22406457
[TBL] [Abstract][Full Text] [Related]
7. Protection in a gerbil model of amebiasis by oral immunization with Salmonella expressing the galactose/N-acetyl D-galactosamine inhibitable lectin of Entamoeba histolytica.
Mann BJ; Burkholder BV; Lockhart LA
Vaccine; 1997; 15(6-7):659-63. PubMed ID: 9178467
[TBL] [Abstract][Full Text] [Related]
8. Immunization with the Entamoeba histolytica surface metalloprotease EhMSP-1 protects hamsters from amebic liver abscess.
Roncolato EC; Teixeira JE; Barbosa JE; Zambelli Ramalho LN; Huston CD
Infect Immun; 2015 Feb; 83(2):713-20. PubMed ID: 25452550
[TBL] [Abstract][Full Text] [Related]
9. Activation of dendritic cells by the Gal-lectin of Entamoeba histolytica drives Th1 responses in vitro and in vivo.
Ivory CP; Chadee K
Eur J Immunol; 2007 Feb; 37(2):385-94. PubMed ID: 17219364
[TBL] [Abstract][Full Text] [Related]
10. Prospect for an Entamoeba histolytica Gal-lectin-based vaccine.
Gaucher D; Chadee K
Parasite Immunol; 2003 Feb; 25(2):55-8. PubMed ID: 12791100
[TBL] [Abstract][Full Text] [Related]
11. Nanoformulation of synergistic TLR ligands to enhance vaccination against Entamoeba histolytica.
Abhyankar MM; Noor Z; Tomai MA; Elvecrog J; Fox CB; Petri WA
Vaccine; 2017 Feb; 35(6):916-922. PubMed ID: 28089548
[TBL] [Abstract][Full Text] [Related]
12. Development of amebicidal cell-mediated immunity in gerbils (Meriones unguiculatus) immunized with the galactose-inhibitable adherence lectin of Entamoeba histolytica.
Schain DC; Salata RA; Ravdin JI
J Parasitol; 1995 Aug; 81(4):563-8. PubMed ID: 7623198
[TBL] [Abstract][Full Text] [Related]
13. Identification of an epitope on the Entamoeba histolytica 170-kD lectin conferring antibody-mediated protection against invasive amebiasis.
Lotter H; Zhang T; Seydel KB; Stanley SL; Tannich E
J Exp Med; 1997 May; 185(10):1793-801. PubMed ID: 9151705
[TBL] [Abstract][Full Text] [Related]
14. Entamoeba histolytica: from adherence to enteropathy.
Ravdin JI
J Infect Dis; 1989 Mar; 159(3):420-9. PubMed ID: 2536786
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the PE
Martínez-Hernández SL; Becerra-González VM; Muñoz-Ortega MH; Loera-Muro VM; Ávila-Blanco ME; Medina-Rosales MN; Ventura-Juárez J
J Immunol Res; 2021; 2021():6697900. PubMed ID: 33824880
[No Abstract] [Full Text] [Related]
16. A recombinant cysteine-rich section of the Entamoeba histolytica galactose-inhibitable lectin is efficacious as a subunit vaccine in the gerbil model of amebic liver abscess.
Soong CJ; Kain KC; Abd-Alla M; Jackson TF; Ravdin JI
J Infect Dis; 1995 Mar; 171(3):645-51. PubMed ID: 7876611
[TBL] [Abstract][Full Text] [Related]
17. Identification of the Entamoeba histolytica galactose-inhibitable lectin epitopes recognized by human immunoglobulin A antibodies following cure of amebic liver abscess.
Abd-Alla MD; Jackson TF; Soong GC; Mazanec M; Ravdin JI
Infect Immun; 2004 Jul; 72(7):3974-80. PubMed ID: 15213142
[TBL] [Abstract][Full Text] [Related]
18. Antigenicity, immunogenicity and vaccine efficacy of the galactose-specific adherence protein of Entamoeba histolytica.
Ravdin JI; Shain DC; Kelsall BL
Vaccine; 1993; 11(2):241-6. PubMed ID: 8438621
[TBL] [Abstract][Full Text] [Related]
19. Oral immunization with an attenuated vaccine strain of Salmonella typhimurium expressing the serine-rich Entamoeba histolytica protein induces an antiamebic immune response and protects gerbils from amebic liver abscess.
Zhang T; Stanley SL
Infect Immun; 1996 May; 64(5):1526-31. PubMed ID: 8613356
[TBL] [Abstract][Full Text] [Related]
20. Protection of gerbils from amebic liver abscess by vaccination with a 25-mer peptide derived from the cysteine-rich region of Entamoeba histolytica galactose-specific adherence lectin.
Lotter H; Khajawa F; Stanley SL; Tannich E
Infect Immun; 2000 Aug; 68(8):4416-21. PubMed ID: 10899838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
